Group One Trading, L.P. Cytom X Therapeutics, Inc. Transaction History
Group One Trading, L.P.
- $3.01 Billion
- Q2 2024
A detailed history of Group One Trading, L.P. transactions in Cytom X Therapeutics, Inc. stock. As of the latest transaction made, Group One Trading, L.P. holds 16,964 shares of CTMX stock, worth $16,964. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16,964
Previous 637
2563.11%
Holding current value
$16,964
Previous $1,000
1900.0%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding CTMX
# of Institutions
75Shares Held
50.4MCall Options Held
22.3KPut Options Held
22.9K-
Tang Capital Management LLC San Diego, CA7.79MShares$7.79 Million1.16% of portfolio
-
Janus Henderson Group PLC London, X06.3MShares$6.3 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA5.23MShares$5.23 Million0.2% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.89MShares$4.89 Million0.0% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA3MShares$3 Million0.01% of portfolio
About CytomX Therapeutics, Inc.
- Ticker CTMX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 65,950,200
- Market Cap $66M
- Description
- CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical...